# Fellow-eye Study (FE) of LX101 in Subjects With Inherited Retinal Dystrophy

> **NCT06212297** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Innostellar Biotherapeutics Co.,Ltd** · enrollment: 9 (estimated)

## Conditions studied

- Inherited Retinal Dystrophy

## Interventions

- **GENETIC:** LX101

## Key facts

- **NCT ID:** NCT06212297
- **Lead sponsor:** Innostellar Biotherapeutics Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-12
- **Primary completion:** 2025-02-06
- **Final completion:** 2029-03
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06212297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06212297, "Fellow-eye Study (FE) of LX101 in Subjects With Inherited Retinal Dystrophy". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06212297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*